Physician profile
Michael Biersmith
NPI 1053725911
$8,557.34
in general payments reported to CMS, 2019-2025
41 companies · $2,696 in 2025
The $2,696 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $641 · 2022: $1,125 · 2023: $1,675 · 2024: $2,320 · 2025: $2,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,473 · Travel and Lodging: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,472.60 |
| Travel and Lodging | $218.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $820.42 | 2022-2025 | Jardiance |
| Shockwave Medical, INC | $725.90 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $710.89 | 2021-2025 | Repatha, Repatha |
| Penumbra, INC. | $618.26 | 2023-2025 | Indigo System |
| Boston Scientific Corporation | $572.22 | 2022-2025 | Avvigo Guidance System, Watchman Flx, Cds - Mct/Cem Monitoring |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $499.54 | 2023-2025 | Lifevest |
| Abbott Laboratories | $467.83 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Diamondback Coronary |
| Pfizer INC. | $464.68 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $356.02 | 2022-2025 | |
| Medtronic, INC. | $307.59 | 2021-2024 | Symplicity G3, Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $292.26 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Edwards Lifesciences Corporation | $273.82 | 2022-2025 | Evoque |
| Sanofi-Aventis U.S. LLC | $215.36 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $198.89 | 2023-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $184.03 | 2024-2025 | Onpattro |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $176.91 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $164.15 | 2023-2025 | Alphavac |
| Siemens Medical Solutions USA, INC. | $160.65 | 2023 | Biograph Horizon-3r |
| Astrazeneca Pharmaceuticals LP | $149.67 | 2021-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $137.12 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $132.70 | 2022-2023 | Arcalyst |
| Philips North America LLC | $111.00 | 2024-2025 | Ecc Solutions, (Ck4) Mcot, Mcot |
| Janssen Pharmaceuticals, INC | $106.76 | 2023-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $102.09 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $76.35 | 2025 | Attruby |
| Abiomed | $60.28 | 2022-2025 | |
| Cardiva Medical, INC. | $58.63 | 2025 | Optowire |
| Cordis US Corp. | $46.72 | 2024 | Mynx Control, Infiniti |
| Lilly USA, LLC | $45.40 | 2023-2025 | Zepbound, Mounjaro |
| Thrombolex, INC. | $44.40 | 2025 | Bashir Endovascular Catheter |
| Lexicon Pharmaceuticals, INC. | $39.60 | 2024 | |
| Surmodics, INC. | $39.09 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| United Therapeutics Corporation | $28.90 | 2025 | Tyvaso |
| Merck Sharp & Dohme LLC | $25.58 | 2025 | Winrevair |
| Inspire Medical Systems, INC. | $25.13 | 2025 | Inspire |
| Catheter Precision INC. | $24.63 | 2024 | |
| Daiichi Sankyo INC. | $21.50 | 2022 | |
| Teleflex LLC | $19.33 | 2022 | |
| Glaxosmithkline, LLC. | $19.23 | 2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $18.55 | 2024 | |
| Azurity Pharmaceuticals, INC. | $15.26 | 2023 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Biersmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.